Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.

Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Abstract Text:

    joanne e mccoubrieJoanne E McCoubrie,susanne k millerSusanne K Miller,tobias sargeantTobias Sargeant,robert t goodRobert T Good,anthony n hodderAnthony N Hodder,terence p speedTerence P Speed,tania f de koning-wardTania F de Koning-Ward,brendan s crabbBrendan S Crabb,joanne e mccoubrieJoanne E McCoubrie,susanne k millerSusanne K Miller,tobias sargeantTobias Sargeant,robert t goodRobert T Good,anthony n hodderAnthony N Hodder,terence p speedTerence P Speed,tania f de koning-wardTania F de Koning-Ward,brendan s crabbBrendan S Crabb,

    Serine repeat antigens (SERAs) are a family of secreted "cysteine-like" proteases of Plasmodium parasites. Several SERAs possess an atypical active-site serine residue in place of the canonical cysteine. The human malaria parasite Plasmodium falciparum possesses six "serine-type" (SERA1 to SERA5 and SERA9) and three "cysteine-type" (SERA6 to SERA8) SERAs. Here, we investigate the importance of the serine-type SERAs to blood-stage parasite development and examine the extent of functional redundancy among this group. We attempted to knock out the four P. falciparum serine-type SERA genes that have not been disrupted previously. SERA1, SERA4, and SERA9 knockout lines were generated, while only SERA5, the most strongly expressed member of the SERA family, remained refractory to genetic deletion. Interestingly, we discovered that while SERA4-null parasites completed the blood-stage cycle normally, they exhibited a twofold increase in the level of SERA5 mRNA. The inability to disrupt SERA5 and the apparent compensatory increase in SERA5 expression in response to the deletion of SERA4 provides evidence for an important blood-stage function for the serine-type SERAs and supports the notion of functional redundancy among this group. Such redundancy is consistent with our phylogenetic analysis, which reveals a monophyletic grouping of the serine-type SERAs across the genus Plasmodium and a predominance of postspeciation expansion. While SERA5 is to some extent further validated as a target for vaccine and drug development, our data suggest that the expression level of other serine-type SERAs is the only barrier to escape from anti-SERA5-specific interventions.

    Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Publishing Authors By Initials

    je mccoubrieJE McCoubrie,sk millerSK Miller,t sargeantT Sargeant,rt goodRT Good,an hodderAN Hodder,tp speedTP Speed,tf de koning-wardTF de Koning-Ward,bs crabbBS Crabb,je mccoubrieJE McCoubrie,sk millerSK Miller,t sargeantT Sargeant,rt goodRT Good,an hodderAN Hodder,tp speedTP Speed,tf de koning-wardTF de Koning-Ward,bs crabbBS Crabb,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Infection and immunity

    VOLUME: 75

    Page Numbers: 5565-74

    Journal Abbreviation: Infect. Immun.

    ISSN: 1098-5522

    DAY: 24

    MONTH: 09

    YEAR: 2007

    Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 246127

    Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.

    AFFILIATION: The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3050, Australia.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United Kingdom Wellcome T

    GRANT:

    ACRONYM:

    MEDLINETA: Infect Immun

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News